Search

everythinglearnresearchcommunity

for

Search:↓

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Higher CRBP1 levels are linked to more severe alopecia areata.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Finasteride and flutamide can effectively treat hirsutism, with abdominal hairs showing the most sensitivity to the treatment.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

Minoxidil response testing helps predict hair growth success.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Tofacitinib is an effective and safe treatment for alopecia areata.

Hair transplantation effectively treats scalp scars with high success and patient satisfaction.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tph cells are linked to the severity of systemic lupus erythematosus.